Insulin induces insulin receptor degradation in the liver through EphB4
Tóm tắt
Từ khóa
Tài liệu tham khảo
Olefsky, J. M. & Glass, C. K. Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 72, 219–246 (2010).
Saltiel, A. R. & Olefsky, J. M. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45, 1661–1669 (1996).
Li, P. et al. LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes. Nat. Med. 21, 239–247 (2015).
Shanik, M. H. et al. Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care 31, S262–S268 (2008).
Corkey, B. E. Banting lecture 2011: hyperinsulinemia: cause or consequence? Diabetes 61, 4–13 (2012).
Marbán, S. L. & Roth, J. in Lessons from Animal Diabetes VI Vol. 6 (ed Shafrir, E.) (Birkhäuser Boston, 1996).
Destefano, M. B., Stern, J. S. & Castonguay, T. W. Effect of chronic insulin administration on food intake and body weight in rats. Physiol. Behav. 50, 801–806 (1991).
Martin, C., Desai, K. S. & Steiner, G. Receptor and postreceptor insulin resistance induced by in vivo hyperinsulinemia. Can. J. Physiol. Pharmacol. 61, 802–807 (1983).
Rizza, R. A., Mandarino, L. J., Genest, J., Baker, B. A. & Gerich, J. E. Production of insulin resistance by hyperinsulinaemia in man. Diabetologia 28, 70–75 (1985).
Gavin, J. R.III, Roth, J., Neville, D. M.Jr., De Meyts, P. & Buell, D. N. Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. Proc. Natl Acad. Sci. USA 71, 84–88 (1974).
De Meyts, P., Roth, J., Neville, D. M.Jr., Gavin, J. R.III & Lesniak, M. A. Insulin interactions with its receptors: experimental evidence for negative cooperativity. Biochem. Biophys. Res. Commun. 55, 154–161 (1973).
Kobayashi, M. & Olefsky, J. M. Effect of experimental hyperinsulinemia on insulin binding and glucose transport in isolated rat adipocytes. Am. J. Physiol. 235, E53–E62 (1978).
Goldfine, I. D. et al. Decreased binding of insulin to its receptors in rats with hormone induced insulin resistance. Biochem. Biophys. Res. Commun. 53, 852–857 (1973).
Czech, M. P. Insulin action and resistance in obesity and type 2 diabetes. Nat. Med. 23, 804–814 (2017).
Hubbard, S. R. & Till, J. H. Protein tyrosine kinase structure and function. Annu. Rev. Biochem. 69, 373–398 (2000).
Clague, M. J. & Urbé, S. Ubiquitin: same molecule, different degradation pathways. Cell 143, 682–685 (2010).
Choi, E., Zhang, X., Xing, C. & Yu, H. Mitotic checkpoint regulators control insulin signaling and metabolic homeostasis. Cell 166, 567–581 (2016).
Choi, E. et al. Mitotic regulators and the SHP2-MAPK pathway promote IR endocytosis and feedback regulation of insulin signaling. Nat. Commun. 10, 1473 (2019).
Ansarullah et al. Inceptor counteracts insulin signalling in β-cells to control glycaemia. Nature 590, 326–331 (2021).
Giorgio, C. et al. Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation. PLoS ONE 6, e18128 (2011).
Martiny-Baron, G. et al. The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis. Angiogenesis 13, 259–267 (2010).
Li, P. et al. Adipocyte NCoR knockout decreases PPARγ phosphorylation and enhances PPARγ activity and insulin sensitivity. Cell 147, 815–826 (2011).
Li, P. et al. Hematopoietic-derived galectin-3 causes cellular and systemic insulin resistance. Cell 167, 973–984.e12 (2016).
Reznik, Y. & Cohen, O. Insulin pump for type 2 diabetes: use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes. Diabetes Care 36, S219–S225 (2013).
Virtue, S. & Vidal-Puig, A. GTTs and ITTs in mice: simple tests, complex answers. Nat. Metab. 3, 883–886 (2021).
Li, P. et al. Functional heterogeneity of CD11c-positive adipose tissue macrophages in diet-induced obese mice. J. Biol. Chem. 285, 15333–15345 (2010).